Cancer Family
Head and Neck Neoplasm
CI-CAN-00000021Explore in graph →
Non-malignant1,572 active trials17 approved drugs142 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000021Explore in graph →
Clinical trials
6,373 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005814 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Advanced Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020189 | Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00332865 | Swallow Exercise as Prophylaxis of Dysphagia After Radiotherapy | completed | Phase 1 / Phase 2 | 60 | University of AarhusOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00400426 | DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer | completed | Phase 2 | 100 | University of AarhusOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006033 | Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | — | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00410826 | Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 2 | 204 | University of WashingtonOTHER | 1 | May 10, 2013 | clinicaltrials |
| NCT00114790 | Boronophenylalanine (BPA)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment Head and Neck Tumors | completed | Phase 1 / Phase 2 | 30 | Boneca CorporationINDUSTRY | 1 | May 6, 2013 | clinicaltrials |
| NCT00056004 | Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | completed | Phase 2 | 38 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 29, 2013 | clinicaltrials |
| NCT00003908 | S9902 Docetaxel Plus Carboplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 68 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 18, 2013 | clinicaltrials |
| NCT00003264 | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer | completed | Phase 2 | 22 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021333 | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer | completed | Phase 2 | 29 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00004161 | Fenretinide in Treating Patients With Leukoplakia of the Mouth | completed | Phase 2 | 30 | University of Alabama at BirminghamOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00006248 | S0007 - Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 2 | 78 | SWOG Cancer Research NetworkNETWORK | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00301028 | Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer | completed | Phase 2 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00243113 | Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx | completed | Phase 2 | 50 | Aichi Cancer CenterOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00096512 | S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT00033618 | Ixabepilone in Treating Patients With Metastatic or Recurrent Squamous Cell Cancer of the Head and Neck | completed | Phase 2 | 144 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT00392704 | Treatment of Head & Neck Cancer With Chemotherapy and Radiation | completed | Phase 2 | 60 | SCRI Development Innovations, LLCOTHER | 1 | Feb 22, 2013 | clinicaltrials |
| NCT00024089 | Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00057850 | BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer | completed | Phase 1 / Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003850 | Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 47 | National Cancer Institute (NCI)NIH | 1 | Feb 8, 2013 | clinicaltrials |
| NCT00002964 | Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer | completed | Phase 2 | — | Roswell Park Cancer InstituteOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT00007982 | Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer | completed | Phase 2 | 30 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00251316 | Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer | completed | Phase 2 | 34 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00005035 | Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer | completed | Phase 2 | — | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Jan 31, 2013 | clinicaltrials |
| NCT00305734 | Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00077428 | Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00064103 | Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00014404 | Celecoxib in Treating Patients With Precancerous Lesions of the Mouth | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 16, 2013 | clinicaltrials |
| NCT00063895 | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck | completed | Phase 1 / Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 9, 2013 | clinicaltrials |
| NCT00003193 | Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 1 / Phase 2 | 37 | Massachusetts General HospitalOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00899054 | Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer(SPARK) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Nov 22, 2012 | clinicaltrials |
| NCT00714649 | Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery(CHIRON) | completed | Phase 1 / Phase 2 | 34 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT01280318 | Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery(HNSCC) | completed | Phase 1 / Phase 2 | 60 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Nov 14, 2012 | clinicaltrials |
| NCT00352105 | Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer | completed | Phase 1 / Phase 2 | 60 | David AdelsteinOTHER | 1 | Nov 5, 2012 | clinicaltrials |
| NCT00276523 | PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery | completed | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2012 | clinicaltrials |
| NCT00100789 | S0329, Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer | completed | Phase 2 | 67 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 1, 2012 | clinicaltrials |
| NCT01213030 | Clinical Evaluation of the New Hypoxia Imaging Agent HX4 | completed | Phase 1 / Phase 2 | 12 | Siemens Molecular ImagingINDUSTRY | 1 | Sep 25, 2012 | clinicaltrials |
| NCT00017498 | Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck | completed | Phase 2 | 21 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Sep 24, 2012 | clinicaltrials |
| NCT00639769 | Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 2 | 41 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00778908 | Late-Course Accelerated Hyperfractionated IMRT for Locoregionally Advanced Nasopharyngeal Carcinoma | completed | Phase 2 / Phase 3 | 120 | Guangxi Medical UniversityOTHER | 1 | Aug 21, 2012 | clinicaltrials |
| NCT00485485 | Imatinib Mesylate (Gleevec) and Docetaxel in Patients With Head and Neck Squamous Cell Cancer | completed | Phase 2 | 7 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 7, 2012 | clinicaltrials |
| NCT00022594 | Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer | completed | Phase 2 | 50 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 10 | Jul 24, 2012 | clinicaltrials |
| NCT01645748 | Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer(TPSHNSCC) | completed | Phase 2 | 35 | Chonnam National University HospitalOTHER | 1 | Jul 20, 2012 | clinicaltrials |
| NCT00094055 | Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer | completed | Phase 2 | 60 | PfizerINDUSTRY | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00058006 | Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer | completed | Phase 2 | — | Northwestern UniversityOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT01616316 | Efficacy of Subfascial Approach in Thyroidectomy to Quality of Life in Thyroid Disease Patients | completed | Phase 2 / Phase 3 | 86 | Samsung Medical CenterOTHER | 1 | Jun 11, 2012 | clinicaltrials |
| NCT00261703 | Docetaxel in Head and Neck Cancer | completed | Phase 2 / Phase 3 | 439 | SanofiINDUSTRY | 2 | May 11, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 19, 2013source: clinicaltrials